BioAge Labs | Targeting metabolic aging
WEBJun 21, 2024 · Our human-first discovery platform analyzes proprietary multi-omics data captured over decades to identify the molecular mediators of aging and disease. Our pipeline programs target key pathways that drive metabolic aging based on novel insights from our platform.
BioAge Labs | About us - Discovery
WEBOur leadership team has diverse professional experience across the biopharma ecosystem and an established track record of success, involved in 95+ regulatory approvals.
BioAge Labs | Platform - Discovery
WEBBioAge’s human-first platform identifies novel metabolic aging targets by analyzing proprietary longitudinal human samples and detailed health records spanning 45+ years.
BioAge Labs | Company
WEBBioAge takes a human-centric, data-driven approach to identify the molecular features of healthy aging and reveal the causes of age-related diseases. By targeting aging with a large and mechanistically diverse portfolio of drugs, we will unlock opportunities to treat or even prevent these diseases in entirely new ways.
BioAge Labs | About Aging - Discovery
WEBSensory declines in vision, hearing, and smell diminish independence and lead to social isolation, a major driver of depression and morbidity. Impaired immunity increases hospitalization and death from infections and decreases vaccine efficacy in the elderly.
BioAge Labs | Events - Discovery
WEBApr 29, 2024 · NASDAQ tower announcement. On the big screen in Times Square, NASDAQ helps us celebrate our $170M Series D to accelerate clinical development for obesity therapeutics. The BioAge mission is to extend healthy lifespan by developing treatments that target the molecular causes of human aging.
BioAge Labs | Azelaprag - Discovery
WEBAzelaprag (BGE-105) Apelin receptor APJ agonist. Lead indication: obesity. Potential for best-in-class oral weight loss in obesity, if approved. Azelaprag is an apelin receptor APJ agonist that increases weight loss and improves body composition in …
BioAge Labs | Pipeline - Discovery
WEBOur lead program, azelaprag, has potential to be a first and best-in-class oral weight loss therapy co-administered with GLP-1 to achieve injectable-like total weight loss and improved body composition.
BioAge Labs | Careers - Discovery
WEBBioAge is committed to discovering new drugs for metabolic disease through the lens of aging biology — improving wellness throughout the lifespan and helping people enjoy longer, healthier lives. We are always seeking talented individuals who share our passion to join us in our mission.
BioAge Labs | Investors - Discovery
WEBBioAge has raised $127M to date from premier investors at the intersection of technology and drug development. They share our passion to address the significant but neglected morbidity that accompanies advanced age.
- Some results have been removed